This page shows the latest pneumococcal conjugate vaccine news and features for those working in and with pharma, biotech and healthcare.
As the first new pneumococcal conjugate vaccine (PCV) in over a decade, we hope to see the new generation of pneumococcal vaccines assessed holistically by the UK health system,” Herath added. ... a catch-up setting for older children who are either
Pfizer has launched a new study of its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) along with a booster dose of its BioNTech-partnered COVID-19 jab. ... 20vPnC includes capsular polysaccharide conjugates for the 13 serotypes in Pfizer’s
Merck &Co (MSD) has been given a fast-track designation for its next-generation 15-valent pneumococcal conjugate vaccine candidate V114. ... If approved, Merck’s V114 will be a close competitor of Pfizer's Prevnar-13, although Pfizer is seeking to
its 15-valent pneumococcal conjugate vaccine candidate V114. ... For more than a century, Merck inventors have developed vaccines that help tackle some of society’s biggest public health challenges, and that heritage is reflected today in our
New-generation shot could protect franchise from rival Merck &Co. Pfizer says it could be on course to file for approval of its new generation pneumococcal conjugate vaccine in the US ... Merck is hoping to muscle into Prevnar 13’s position in
Rivals look to broaden coverage across strains. Pfizer just got a leg-up in its race with Merck &Co to bring a new-generation pneumococcal vaccine to the US market after ... continue to build on our expertise in pneumococcal conjugate vaccines with this
More from news
Approximately 1 fully matching, plus 14 partially matching documents found.
26.6. ‡SK Chemicals/ Sanofi Pasteur. Collaboration. Pneumococcal conjugate vaccine (PCV). 23.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...